Our experience with 80 cases of SARS-CoV-2-Clostridioides difficile co-infection: An observational study
Open Access
- 8 July 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (27) , e29823
Abstract
Beside the changes in the gut microbiota in context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the increased use of high-risk broad-spectrum antibiotics during the actual pandemic raises concerns about a possible increase of Clostridioides difficile infections (CDIs). We retrospectively analyzed 80 consecutive patients, with SARS-CoV-2 pneumonia and CDI. The mean length of hospitalization was 19.63 days. The mean time of the onset of the digestive symptoms related to CDI was 5.16 days. Patients with an onset of the digestive symptoms from hospital admission have a significantly lower median length in hospital stay. The recovered patients present a statistically significant decreased median age. coronavirus disease 2019 (COVID-19) cured patients present CDI symptoms much earlier than the deceased patients, when comparing the median days before the occurrence of any digestive symptoms regarding CDI. Among the patients that prior to their hospitalization for COVID-19 were exposed to antibiotics, 54.7% presented CDI digestive symptoms during their hospitalization and 65.6% had a severe or critical COVID-19 form. Although the incidence of CDI in the pandemic is lower compared to the period before the pandemic, the severity of cases and the death rate increased. In the actual setting clinicians need to be aware of possible CDI and SARS-CoV-2 co-infection.Keywords
This publication has 25 references indexed in Scilit:
- Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March–April 2020Emerging Infectious Diseases, 2020
- Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut MicrobiomeAmerican Journal of Hypertension, 2020
- Role of gut microbiota in cardiovascular diseasesWorld Journal of Cardiology, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell FunctionMolecules, 2019
- Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017Eurosurveillance, 2018
- The Need for European Surveillance of CDI2018
- ACE2 and MicrobiotaJournal of Cardiovascular Pharmacology, 2015
- Asymptomatic Clostridium difficile colonization: epidemiology and clinical implicationsBMC Infectious Diseases, 2015
- Burden ofClostridium difficileInfection in the United StatesNew England Journal of Medicine, 2015